BHVN
Price
$15.17
Change
-$0.38 (-2.44%)
Updated
Jul 13 closing price
Capitalization
2.28B
20 days until earnings call
Intraday BUY SELL Signals
IMA
Price
$6.11
Change
+$0.20 (+3.38%)
Updated
Jul 13 closing price
Capitalization
68.92M
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BHVN vs IMA

BHVN vs IMA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BHVN vs. IMA commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Buy and IMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (BHVN: $15.17 vs. IMA: $6.11)
Brand notoriety: BHVN and IMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 51% vs. IMA: 37%
Market capitalization -- BHVN: $2.28B vs. IMA: $68.92M
BHVN [@Biotechnology] is valued at $2.28B. IMA’s [@Biotechnology] market capitalization is $68.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileIMA’s FA Score has 1 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • IMA’s FA Score: 1 green, 4 red.
According to our system of comparison, IMA is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 3 TA indicator(s) are bullish while IMA’s TA Score has 6 bullish TA indicator(s).

  • BHVN’s TA Score: 3 bullish, 6 bearish.
  • IMA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMA is a better buy in the short-term than BHVN.

Price Growth

BHVN (@Biotechnology) experienced а -5.48% price change this week, while IMA (@Biotechnology) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

BHVN is expected to report earnings on Aug 03, 2026.

IMA is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($2.28B) has a higher market cap than IMA($68.9M). BHVN YTD gains are higher at: 34.367 vs. IMA (-11.449). IMA has higher annual earnings (EBITDA): -53.41M vs. BHVN (-644.2M). BHVN has more cash in the bank: 348M vs. IMA (117M). IMA has less debt than BHVN: IMA (2.42M) vs BHVN (286M). BHVN (0) and IMA (0) have equivalent revenues.
BHVNIMABHVN / IMA
Capitalization2.28B68.9M3,315%
EBITDA-644.2M-53.41M1,206%
Gain YTD34.367-11.449-300%
P/E RatioN/AN/A-
Revenue00-
Total Cash348M117M297%
Total Debt286M2.42M11,838%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHVNIMA
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BHVN
Daily Signal:
Gain/Loss:
IMA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRSCX33.25N/A
N/A
Nuveen Large Cap Responsible Eq Ret
SPMAX10.87N/A
N/A
Saratoga Mid Capitalization A
AWSCX16.05N/A
N/A
Invesco Global Core Equity C
PJGQX21.87N/A
N/A
PGIM Jennison Mid-Cap Growth R6
SJCIX35.74N/A
N/A
Steward Large Cap Core I

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
+3.38%
CELC - IMA
78%
Closely correlated
-3.52%
SLXN - IMA
62%
Loosely correlated
-2.34%
MNOV - IMA
28%
Poorly correlated
-2.16%
ADIL - IMA
23%
Poorly correlated
+1.80%
BHVN - IMA
22%
Poorly correlated
-2.44%
More